TCCM
IDXX icon

Two Creeks Capital Management’s Idexx Laboratories IDXX Stock Holding History

Two Creeks Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-114,459
Closed -$61.4M – 26
2025
Q2 		$61.4M Sell
114,459
-45,795
-29% -$21.9M 4.02% 14
2025
Q1 		$67.3M Buy
160,254
+91,144
+132% +$39.6M 4.3% 10
2024
Q4 		$28.6M Buy
+69,110
New +$30.3M 1.74% 20

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Two Creeks Capital Management's IDXX Position: Q3 2025 in Review

Two Creeks Capital Management sold out of Idexx Laboratories (IDXX) in Q3 2025, closing a stake of 114,459 shares — an estimated $61.4M sold.

Two Creeks Capital Management first reported a position in IDXX in Q4 2024 and held it in 3 quarters. The position peaked at $67.3M in Q1 2025. 1,303 funds tracked by Wall St. Rank hold IDXX as of Q3 2025.

  • Two Creeks Capital Management reported no remaining Idexx Laboratories position as of Q3 2025 after selling out during the quarter.
  • Two Creeks Capital Management sold 114,459 Idexx Laboratories shares in Q3 2025, an estimated $61.4M.
  • Two Creeks Capital Management first reported a position in Idexx Laboratories in Q4 2024 and held it in 3 quarters.
  • Two Creeks Capital Management's Idexx Laboratories position peaked at $67.3M in Q1 2025.
  • 1,303 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2025.

Based on Two Creeks Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.